Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors.

Garufi G, Palazzo A, Paris I, Orlandi A, Cassano A, Tortora G, Scambia G, Bria E, Carbognin L.

Expert Opin Pharmacother. 2020 Feb 13:1-13. doi: 10.1080/14656566.2020.1724957. [Epub ahead of print]

PMID:
32052646
2.

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.

Krasniqi E, Pizzuti L, Barchiesi G, Sergi D, Carpano S, Botti C, Kayal R, Sanguineti G, Marchetti P, Botticelli A, Marinelli D, Gamucci T, Natoli C, Grassadonia A, Tinari N, Tomao S, Tonini G, Santini D, Michelotti A, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Cazzaniga M, Moscetti L, Fabbri A, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Garufi C, Di Stefano P, Mirabelli R, Veltri E, Paris I, Giotta F, Lorusso V, Landucci E, Ficorella C, Roselli M, Adamo V, Ricciardi G, Russo A, Valerio MR, Berardi R, Pistelli M, Cannita K, Zamagni C, Garrone O, Baldini E, Livi L, Meattini I, Del Medico P, Generali D, De Maria R, Risi E, Ciliberto G, Villa A, Sperduti I, Mazzotta M, Barba M, Giordano A, Vici P.

J Cell Physiol. 2020 Jan 15. doi: 10.1002/jcp.29445. [Epub ahead of print]

PMID:
31943171
3.

Microglia Actively Remodel Adult Hippocampal Neurogenesis through the Phagocytosis Secretome.

Diaz-Aparicio I, Paris I, Sierra-Torre V, Plaza-Zabala A, Rodríguez-Iglesias N, Márquez-Ropero M, Beccari S, Huguet P, Abiega O, Alberdi E, Matute C, Bernales I, Schulz A, Otrokocsi L, Sperlagh B, Happonen KE, Lemke G, Maletic-Savatic M, Valero J, Sierra A.

J Neurosci. 2020 Feb 12;40(7):1453-1482. doi: 10.1523/JNEUROSCI.0993-19.2019. Epub 2020 Jan 2.

PMID:
31896673
4.

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives.

Carbognin L, Miglietta F, Paris I, Dieci MV.

Cancers (Basel). 2019 Sep 19;11(9). pii: E1401. doi: 10.3390/cancers11091401. Review.

5.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7.

PMID:
31330065
6.

Ultrasound morphometric and cytologic preoperative assessment of inguinal lymph node status in women with vulvar cancer: the MorphoNode study.

Garganese G, Fragomeni SM, Pasciuto T, Leombroni M, Moro F, Evangelista MT, Bove S, Gentileschi S, Tagliaferri L, Paris I, Inzani F, Fanfani F, Scambia G, Testa AC.

Ultrasound Obstet Gynecol. 2019 Jun 25. doi: 10.1002/uog.20378. [Epub ahead of print]

PMID:
31237047
7.

The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year.

Paris I, Henry C, Pirard F, Gérard AC, Colin IM.

Endocrinol Diabetes Metab. 2018 Jun 17;1(3):e00023. doi: 10.1002/edm2.23. eCollection 2018 Jul.

8.

Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression.

Simonneau M, Frouin E, Huguier V, Jermidi C, Jégou JF, Godet J, Barra A, Paris I, Levillain P, Cordier-Dirikoc S, Pedretti N, Bernard FX, Lecron JC, Morel F, Favot L.

Oncotarget. 2018 Nov 23;9(92):36457-36473. doi: 10.18632/oncotarget.26355. eCollection 2018 Nov 23.

9.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

Pizzuti L, Giordano A, Michelotti A, Mazzotta M, Natoli C, Gamucci T, De Angelis C, Landucci E, Diodati L, Iezzi L, Mentuccia L, Fabbri A, Barba M, Sanguineti G, Marchetti P, Tomao S, Mariani L, Paris I, Lorusso V, Vallarelli S, Cassano A, Aroldi F, Orlandi A, Moscetti L, Sergi D, Sarobba MG, Tonini G, Santini D, Sini V, Veltri E, Vaccaro A, Ferrari L, De Tursi M, Tinari N, Grassadonia A, Greco F, Botticelli A, La Verde N, Zamagni C, Rubino D, Cortesi E, Magri V, Pomati G, Scagnoli S, Capomolla E, Kayal R, Scinto AF, Corsi D, Cazzaniga M, Laudadio L, Forciniti S, Mancini M, Carbognin L, Seminara P, Barni S, Samaritani R, Roselli M, Portarena I, Russo A, Ficorella C, Cannita K, Carpano S, Pistelli M, Berardi R, De Maria R, Sperduti I, Ciliberto G, Vici P.

J Cell Physiol. 2019 Jun;234(6):7708-7717. doi: 10.1002/jcp.27832. Epub 2018 Dec 10.

PMID:
30536609
10.

Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients.

Rizza R, Hackmann K, Paris I, Minucci A, De Leo R, Schrock E, Urbani A, Capoluongo E, Gelli G, Concolino P.

Mol Diagn Ther. 2019 Feb;23(1):121-126. doi: 10.1007/s40291-018-0376-2.

PMID:
30506513
11.

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.

Gamucci T, Pizzuti L, Natoli C, Mentuccia L, Sperduti I, Barba M, Sergi D, Iezzi L, Maugeri-Saccà M, Vaccaro A, Magnolfi E, Gelibter A, Barchiesi G, Magri V, D'Onofrio L, Cassano A, Rossi E, Botticelli A, Moscetti L, Omarini C, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Mazzotta M, Bria E, Foglietta J, Samaritani R, Garufi C, Mariani L, Barni S, Mirabelli R, Sarmiento R, Graziano V, Santini D, Marchetti P, Tonini G, Di Lauro L, Sanguineti G, Paoletti G, Tomao S, De Maria R, Veltri E, Paris I, Giotta F, Latorre A, Giordano A, Ciliberto G, Vici P.

Cancer Biol Ther. 2019;20(2):192-200. doi: 10.1080/15384047.2018.1523095. Epub 2018 Nov 7.

12.

Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer.

Paris I, Cianci S, Vizzielli G, Fagotti A, Ferrandina G, Gueli Alletti S, Costantini B, Cosentino F, Capoluongo E, Pasqualoni M, Scambia G.

Int J Hyperthermia. 2018;35(1):370-374. doi: 10.1080/02656736.2018.1503346. Epub 2018 Oct 9.

PMID:
30300042
13.

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.

Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F.

Breast. 2018 Oct;41:137-143. doi: 10.1016/j.breast.2018.07.004. Epub 2018 Jul 12.

PMID:
30092500
14.

Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome.

Minucci A, Concolino P, De Bonis M, Costella A, Paris I, Scambia G, Capoluongo E.

Hum Genome Var. 2018 Apr 20;5:2. doi: 10.1038/s41439-018-0003-0. eCollection 2018.

15.

ProMoIJ: A new tool for automatic three-dimensional analysis of microglial process motility.

Paris I, Savage JC, Escobar L, Abiega O, Gagnon S, Hui CW, Tremblay MÈ, Sierra A, Valero J.

Glia. 2018 Apr;66(4):828-845. doi: 10.1002/glia.23287. Epub 2017 Dec 30.

PMID:
29288586
16.

Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.

Santonocito C, Scapaticci M, Guarino D, Bartolini A, Minucci A, Concolino P, Scambia G, Paris I, Capoluongo E.

Breast. 2017 Dec;36:74-78. doi: 10.1016/j.breast.2017.09.007. Epub 2017 Oct 8.

PMID:
29020660
17.

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi A, De Laurentiis M, Caruso M, Valle E, Moscetti L, Santini D, Cannita K, Carbognin L, Ciccarese M, Rossello R, Arpino G, Leonardi V, Montemurro F, La Verde N, Generali D, Zambelli A, Scandurra G, Russillo M, Paris I, D'Ottavio AM, Filippelli G, Giampaglia M, Stani S, Fabbri A, Alesini D, Cianniello D, Giannarelli D, Cognetti F.

Oncotarget. 2017 Mar 18;8(38):64481-64489. doi: 10.18632/oncotarget.16373. eCollection 2017 Sep 8.

18.

Brain metastases and ado-trastuzumab emtansine (TDM-1) treatment in HER2 positive metastatic patients: an Italian multicenter analysis.

Fabi A, Alesini D, Valle E, Carbognin L, Arpino G, Santini D, Montemurro F, Ciccarese M, Cannita K, Paris I, Moscetti L, De Laurentiis M, Zambelli A, La Verde N, Nisticò C, Ferretti G, Gasparro S, Giannarelli D, Cognetti F.

Ann Oncol. 2017 Oct;28 Suppl 6:vi27. doi: 10.1093/annonc/mdx424.007. No abstract available.

19.

Efficacy of pertuzumab in combination with trastuzumab and a taxane in in first line treatment for metastatic breast cancer (MBC): a multicenter retrospective observational study.

Mentuccia L, Gelibter A, Sperduti I, D'Onofrio L, Botticelli A, Vici P, Cassano A, Moscetti L, Carbognin L, Graziano V, Barchiesi G, Rossi E, Cursano MC, Pizzuti L, Paris I, Vaccaro A, Fabbri A, Rossi L, Samaritani R, Sarmiento R, Gamucci T.

Ann Oncol. 2017 Oct;28 Suppl 6:vi26. doi: 10.1093/annonc/mdx424.004. No abstract available.

20.

Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey.

Ferrandina G, Amadio G, Paris I, Distefano M, Palluzzi E, de Vincenzo R, Ricci C, Scambia G.

Int J Gynecol Cancer. 2017 Jul;27(6):1141-1148. doi: 10.1097/IGC.0000000000001058.

PMID:
28574933
21.

BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.

Petrillo M, Marchetti C, De Leo R, Musella A, Capoluongo E, Paris I, Benedetti Panici P, Scambia G, Fagotti A.

Am J Obstet Gynecol. 2017 Sep;217(3):334.e1-334.e9. doi: 10.1016/j.ajog.2017.05.036. Epub 2017 May 23.

PMID:
28549976
22.

Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome.

Concolino P, Rizza R, Hackmann K, Paris I, Minucci A, De Paolis E, Scambia G, Zuppi C, Schrock E, Capoluongo E.

Breast Cancer Res Treat. 2017 Jul;164(2):497-503. doi: 10.1007/s10549-017-4275-8. Epub 2017 May 9.

PMID:
28488140
23.

Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.

Roberto M, Romiti A, Botticelli A, Mazzuca F, Lionetto L, Gentile G, Paris I, Falcone R, Bassanelli M, Di Pietro FR, Onesti CE, Anselmi E, Macrini S, Simmaco M, Marchetti P.

Eur J Clin Pharmacol. 2017 Feb;73(2):157-164. doi: 10.1007/s00228-016-2160-8. Epub 2016 Nov 18.

PMID:
27864592
24.
25.

Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D, Domercq M, Pérez-Samartín A, Sánchez-Zafra V, Paris I, Valero J, Savage JC, Hui CW, Tremblay MÈ, Deudero JJ, Brewster AL, Anderson AE, Zaldumbide L, Galbarriatu L, Marinas A, Vivanco MD, Matute C, Maletic-Savatic M, Encinas JM, Sierra A.

PLoS Biol. 2016 Sep 20;14(9):e1002554. doi: 10.1371/journal.pbio.1002554. eCollection 2016 Sep.

26.

In vitro culture and phenotypic and molecular characterization of gastric stem cells from human stomach.

Garcia M, Chomel JC, Mustapha P, Tran CT, Garnier M, Paris I, Quellard N, Godet J, Cremniter J, Bennaceur-Griscelli A, Lecron JC, Turhan AG, Burucoa C, Bodet C.

Helicobacter. 2017 Apr;22(2). doi: 10.1111/hel.12351. Epub 2016 Sep 4.

PMID:
27592706
27.

Corrigendum: Commentary: Evaluation of Models of Parkinson's Disease.

Muñoz P, Paris I, Segura-Aguilar J.

Front Neurosci. 2016 Jul 7;10:320. doi: 10.3389/fnins.2016.00320. eCollection 2016.

28.

Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D, Domercq M, Pérez-Samartín A, Sánchez-Zafra V, Paris I, Valero J, Savage JC, Hui CW, Tremblay MÈ, Deudero JJ, Brewster AL, Anderson AE, Zaldumbide L, Galbarriatu L, Marinas A, Vivanco MD, Matute C, Maletic-Savatic M, Encinas JM, Sierra A.

PLoS Biol. 2016 Jun 30;14(6):e1002508. doi: 10.1371/journal.pbio.1002508. eCollection 2016 Jun.

29.

Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D, Domercq M, Pérez-Samartín A, Sánchez-Zafra V, Paris I, Valero J, Savage JC, Hui CW, Tremblay MÈ, Deudero JJ, Brewster AL, Anderson AE, Zaldumbide L, Galbarriatu L, Marinas A, Vivanco Md, Matute C, Maletic-Savatic M, Encinas JM, Sierra A.

PLoS Biol. 2016 May 26;14(5):e1002466. doi: 10.1371/journal.pbio.1002466. eCollection 2016 May. Erratum in: PLoS Biol. 2016 Jun;14(6):e1002508. PLoS Biol. 2016 Sep;14(9):e1002554.

30.

Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study.

Petrillo M, Amadio G, Salutari V, Paris I, Di Stefano MG, Ferandina G, Scambia G, Fagotti A.

Gynecol Oncol. 2016 Aug;142(2):231-6. doi: 10.1016/j.ygyno.2016.05.017. Epub 2016 May 26.

PMID:
27215633
31.

DT-diaphorase protects astrocytes from aminochrome-induced toxicity.

Huenchuguala S, Muñoz P, Graumann R, Paris I, Segura-Aguilar J.

Neurotoxicology. 2016 Jul;55:10-12. doi: 10.1016/j.neuro.2016.04.014. Epub 2016 May 7.

PMID:
27168424
32.

Commentary: Evaluation of Models of Parkinson's Disease.

Muñoz P, Paris I, Segura-Aguilar J.

Front Neurosci. 2016 Apr 19;10:161. doi: 10.3389/fnins.2016.00161. eCollection 2016. No abstract available. Erratum in: Front Neurosci. 2016;10:320.

33.

Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.

Pohin M, Guesdon W, Mekouo AA, Rabeony H, Paris I, Atanassov H, Favot L, Mcheik J, Bernard FX, Richards CD, Amiaud J, Blanchard F, Lecron JC, Morel F, Jégou JF.

Eur J Immunol. 2016 Jul;46(7):1737-51. doi: 10.1002/eji.201546216. Epub 2016 May 12.

34.

Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.

Herrera A, Muñoz P, Paris I, Díaz-Veliz G, Mora S, Inzunza J, Hultenby K, Cardenas C, Jaña F, Raisman-Vozari R, Gysling K, Abarca J, Steinbusch HW, Segura-Aguilar J.

Cell Mol Life Sci. 2016 Sep;73(18):3583-97. doi: 10.1007/s00018-016-2182-5. Epub 2016 Mar 21.

PMID:
27001668
35.

Lifestyle Shapes the Dialogue between Environment, Microglia, and Adult Neurogenesis.

Valero J, Paris I, Sierra A.

ACS Chem Neurosci. 2016 Apr 20;7(4):442-53. doi: 10.1021/acschemneuro.6b00009. Epub 2016 Mar 22. Review.

PMID:
26971802
36.

Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.

Costa SL, Silva VD, Dos Santos Souza C, Santos CC, Paris I, Muñoz P, Segura-Aguilar J.

Neurotox Res. 2016 Jul;30(1):41-52. doi: 10.1007/s12640-016-9600-1. Epub 2016 Mar 7. Review.

PMID:
26951456
37.

The need of a new and more physiological preclinical model for Parkinson's disease.

Segura-Aguilar J, Paris I, Muñoz P.

Cell Mol Life Sci. 2016 Apr;73(7):1381-2. doi: 10.1007/s00018-016-2140-2. Epub 2016 Jan 23. No abstract available.

PMID:
26803841
38.
39.

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L.

Prog Neurobiol. 2017 Aug;155:96-119. doi: 10.1016/j.pneurobio.2015.09.012. Epub 2015 Oct 9. Review.

40.

Aminochrome Toxicity is Mediated by Inhibition of Microtubules Polymerization Through the Formation of Adducts with Tubulin.

Briceño A, Muñoz P, Brito P, Huenchuguala S, Segura-Aguilar J, Paris IB.

Neurotox Res. 2016 Apr;29(3):381-93. doi: 10.1007/s12640-015-9560-x. Epub 2015 Sep 7.

PMID:
26345577
41.

Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study.

Petrillo M, Paris I, Vizzielli G, Amadio G, Cosentino F, Salutari V, Scambia G, Fagotti A.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S952-8. doi: 10.1245/s10434-015-4651-8. Epub 2015 Jun 3.

PMID:
26036187
42.

Widespread renal polycystosis induced by crizotinib.

Di Girolamo M, Paris I, Carbonetti F, Onesti EC, Socciarelli F, Marchetti P.

Tumori. 2015 Jul 24;101(4):e128-31. doi: 10.5301/tj.5000338.

PMID:
25953441
43.

DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity.

Muñoz P, Cardenas S, Huenchuguala S, Briceño A, Couve E, Paris I, Segura-Aguilar J.

Toxicol Sci. 2015 May;145(1):37-47. doi: 10.1093/toxsci/kfv016. Epub 2015 Jan 28.

44.

Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.

Cuevas C, Huenchuguala S, Muñoz P, Villa M, Paris I, Mannervik B, Segura-Aguilar J.

Neurotox Res. 2015 Apr;27(3):217-28. doi: 10.1007/s12640-014-9500-1. Epub 2014 Nov 18.

PMID:
25403520
45.

Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.

D'Antonio C, Milano A, Righini R, Onesti CE, Bassanelli M, Falcone R, Paris I, Lauro S, Marchetti P.

Anticancer Res. 2014 Oct;34(10):5241-50. Review.

46.

Chemokines and antimicrobial peptides have a cag-dependent early response to Helicobacter pylori infection in primary human gastric epithelial cells.

Mustapha P, Paris I, Garcia M, Tran CT, Cremniter J, Garnier M, Faure JP, Barthes T, Boneca IG, Morel F, Lecron JC, Burucoa C, Bodet C.

Infect Immun. 2014 Jul;82(7):2881-9. doi: 10.1128/IAI.01517-13. Epub 2014 Apr 28.

47.

Protective and toxic roles of dopamine in Parkinson's disease.

Segura-Aguilar J, Paris I, Muñoz P, Ferrari E, Zecca L, Zucca FA.

J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18. Review.

48.

Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.

Huenchuguala S, Muñoz P, Zavala P, Villa M, Cuevas C, Ahumada U, Graumann R, Nore BF, Couve E, Mannervik B, Paris I, Segura-Aguilar J.

Autophagy. 2014 Apr;10(4):618-30. doi: 10.4161/auto.27720. Epub 2014 Jan 14.

49.

Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasia.

Paris I, Prelaj A, Onesti CE, Baldoni A, Giovagnoli MR, Bassanelli M, Lauro S, Marchetti P.

Anticancer Res. 2014 Jan;34(1):363-6.

50.

IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection.

Guabiraba R, Besnard AG, Marques RE, Maillet I, Fagundes CT, Conceição TM, Rust NM, Charreau S, Paris I, Lecron JC, Renauld JC, Quesniaux V, Da Poian AT, Arruda LB, Souza DG, Ryffel B, Teixeira MM.

Eur J Immunol. 2013 Jun;43(6):1529-44. doi: 10.1002/eji.201243229. Epub 2013 Apr 17.

Supplemental Content

Support Center